Gilead Sciences, Inc. (GILD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 2.54B | 3.33B | 4.11B | 827M | 1.76B | 2.98B | 4.31B | 1.32B | 2.22B | 2.17B | 1.75B | 2.34B |
| Operating CF Margin % | 36.55% | 41.99% | 52.88% | 11.68% | 26.35% | 39.31% | 57.11% | 19.06% | 33.19% | 30.49% | 24.89% | 35.43% |
| Operating CF Growth % | 44.79% | 11.83% | -4.66% | -37.58% | -20.82% | 37.16% | 145.53% | -43.33% | 27.24% | -15.5% | -38.7% | 29.74% |
| Net Income | 2.02B | 2.18B | 3.05B | 1.96B | 1.31B | 1.78B | 1.25B | 1.61B | -4.17B | 1.42B | 2.17B | 1.04B |
| Depreciation & Amortization | 689M | 666M | 686M | 691M | 696M | 693M | 690M | 694M | 690M | 688M | 684M | 681M |
| Stock-Based Compensation | 0 | 0 | 230M | 225M | 209M | 222M | 216M | 210M | 187M | 201M | 202M | 198M |
| Deferred Taxes | 179M | -122M | 659M | -178M | -199M | -379M | -576M | -166M | -723M | -370M | -68M | -221M |
| Other Non-Cash Items | 366M | 1.2B | -222M | 143M | 769M | 173M | 2.08B | 519M | 6.69B | 776M | 314M | 310M |
| Working Capital Changes | -711M | -604M | -297M | -2.01B | -1.03B | 483M | 642M | -1.55B | -459M | -543M | -1.55B | 331M |
| Change in Receivables | 134M | 179M | -333M | -292M | 79M | 72M | 162M | -29M | -66M | 220M | -612M | -86M |
| Change in Inventory | -52M | -123M | -515M | -175M | -223M | -226M | -85M | -70M | -45M | -307M | -82M | -226M |
| Change in Payables | -67M | -95M | 230M | -162M | -105M | -58M | 359M | -83M | 72M | -43M | -29M | -3M |
| Cash from Investing | 1.77B | -1.83B | -427M | -2.12B | -415M | -225M | -710M | -307M | -2.21B | -727M | -229M | -483M |
| Capital Expenditures | -117M | -205M | -147M | -107M | -104M | -147M | -141M | -130M | -105M | -215M | -122M | -139M |
| CapEx % of Revenue | 1.68% | 2.59% | 1.89% | 1.51% | 1.56% | 1.94% | 1.87% | 1.87% | 1.57% | 3.02% | 1.73% | 2.11% |
| Acquisitions | -109M | -609M | -167M | -21M | -273M | -75M | -570M | -152M | -4.04B | -279M | -79M | -243M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -16M | 12M | 3M | 10M | -22M | 36M | 10M | 9M | 3M | 0 | 6M | -1M |
| Cash from Financing | -4.24B | -1.26B | -1.49B | -1.57B | -3.43B | 2.26B | -1.38B | -2.95B | -1.36B | -1.1B | -1.52B | -1.1B |
| Debt Issued (Net) | -2.77B | -8M | -9M | -9M | -1.76B | 3.46B | -112M | -1.85B | 0 | 1M | -271M | 0 |
| Equity Issued (Net) | -253M | -198M | -338M | -500M | -478M | -177M | -202M | -95M | -254M | -124M | -217M | -124M |
| Dividends Paid | -1.04B | -994M | -1B | -994M | -1.01B | -973M | -983M | -972M | -990M | -943M | -953M | -944M |
| Share Repurchases | -419M | -230M | -435M | -527M | -730M | -350M | -300M | -100M | -400M | -150M | -300M | -150M |
| Other Financing | -180M | -63M | -137M | -64M | -176M | -47M | -82M | -35M | -117M | -33M | -78M | -33M |
| Net Change in Cash | 64M | 234M | 2.19B | -2.78B | -2.06B | 4.95B | 2.27B | -1.95B | -1.37B | 380M | 1M | 768M |
| Free Cash Flow | 2.43B | 3.12B | 3.96B | 720M | 1.65B | 2.83B | 4.17B | 1.2B | 2.11B | 1.95B | 1.63B | 2.2B |
| FCF Margin % | 34.87% | 39.39% | 50.98% | 10.17% | 24.79% | 37.36% | 55.24% | 17.19% | 31.62% | 27.47% | 23.16% | 33.32% |
| FCF Growth % | 46.82% | 10.36% | -4.97% | -39.75% | -21.81% | 44.73% | 155.24% | -45.66% | 29.3% | -18.11% | -39.65% | 32.55% |
| FCF per Share | 1.94 | 2.49 | 3.16 | 0.57 | 1.31 | 2.25 | 3.32 | 0.96 | 1.70 | 1.56 | 1.30 | 1.75 |
| FCF Conversion (FCF/Net Income) | 1.26x | 1.52x | 1.35x | 0.42x | 1.34x | 1.67x | 3.44x | 0.82x | -0.53x | 1.52x | 0.81x | 2.24x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |